Fig. 1From: Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancerSampling procedure for TNBC patients prior to ACT chemotherapyBack to article page